Bassel Nazha
- Department of Hematology and Medical Oncology
Assistant Professor
- (404) 251-5996
- bassel.nazha@emory.edu
Academic Appointment
- Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from American University of Beirut
- MPH from Columbia University
Research
Publications
-
Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches.
Oncologist Volume: 29 Page(s): 738 - 746
09/06/2024 Authors: Chukkalore D; MacDougall K; Master V; Bilen MA; Nazha B -
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.
J Natl Cancer Inst Volume: 116 Page(s): 966 - 973
06/07/2024 Authors: Rose KM; Pham R; Zacharias NM; Ionescu F; Paravathaneni M; Marchetti KA; Sanchez D; Mustasam A; Sandstrom R; Vikram R -
Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
Clin Genitourin Cancer Volume: 22 Page(s): 102056
06/01/2024 Authors: Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS -
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Cancer Volume: 129 Page(s): 3884 - 3893
12/15/2023 Authors: Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI -
Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
Oncologist Volume: 28 Page(s): 1072 - 1078
12/11/2023 Authors: Sanda GE; Shabto JM; Goyal S; Liu Y; Martini DJ; Nazha B; Brown JT; Yantorni LB; Anne Russler G; Caulfield S -
The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.
Cancers (Basel) Volume: 15
12/06/2023 Authors: Hadadi A; Krause HB; Elliott A; Brown JT; Nazha B; Harik LR; Carthon BC; Miron B; Nabhan C; Barata PC -
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
J Natl Cancer Inst Volume: 115 Page(s): 1605 - 1615
12/06/2023 Authors: El Zarif T; Nassar AH; Pond GR; Zhuang TZ; Master V; Nazha B; Niglio S; Simon N; Hahn AW; Pettaway CA -
Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match?
J Clin Oncol Volume: 41 Page(s): 2467 - 2470
05/10/2023 Authors: Brown JT; Nazha B; Bilen MA -
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Oncologist Volume: 28 Page(s): 239 - 245
03/17/2023 Authors: Zhuang TZ; Ravindranathan D; Liu Y; Martini DJ; Brown JT; Nazha B; Russler G; Yantorni LB; Caulfield S; Carthon BC -
Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.
J Immunother Precis Oncol Volume: 5 Page(s): 52 - 57
08/01/2022 Authors: Martini DJ; Olsen TA; Goyal S; Liu Y; Evans ST; Hitron EE; Russler GA; Yantorni L; Caulfield S; Brown JT